NIHR | Manchester Biomedical Research Centre
Our Research: Cancer Precision Medicine


Cancer Precision Medicine is only possible because of close links with industry, which provides a platform for the development of innovative new tests and treatments.

These include:

We are a member of the EU IMI Cancer ID consortium optimising liquid biopsies and standardising their measurement across Europe.